ICU Medical (ICUI) Tops Q2 EPS Views; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Roth Capital Raises Price on ICU Medical (ICUI) to $124 Following 2Q EPS Beat and Raise
August 11, 2015 8:17 AM EDTRoth Capital reiterated a Buy rating on ICU Medical (NASDAQ: ICUI), and raised the price target to $124.00 (from $102.00), following the company's 2Q earnings release. 2Q revenues of $83.8 million beat Street's $78.89 million estimate. Adjusted EPS of $0.97 beat Street's $0.69. ICUI raised its annual outlook, which... More
